Affimed NV (LTS:0HL9) Other Operating Expense : $-0.24 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Affimed NV Other Operating Expense?

Affimed NV's Other Operating Expense for the three months ended in Dec. 2023 was $-0.24 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.24 Mil.

Affimed NV's quarterly Other Operating Expense increased from Jun. 2023 ($-0.00 Mil) to Sep. 2023 ($-0.00 Mil) but then declined from Sep. 2023 ($-0.00 Mil) to Dec. 2023 ($-0.24 Mil).

Affimed NV's annual Other Operating Expense declined from Dec. 2021 ($-0.39 Mil) to Dec. 2022 ($-0.60 Mil) but then increased from Dec. 2022 ($-0.60 Mil) to Dec. 2023 ($-0.24 Mil).

Affimed NV Other Operating Expense Historical Data

The historical data trend for Affimed NV's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV Other Operating Expense Chart

Affimed NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

-0.02

-0.42

-0.39

-0.60

-0.24

Affimed NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															-0.60	-	-	-	-0.24

Affimed NV Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24 Mil.

Affimed NV Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Affimed NV's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Affimed NV (LTS:0HL9) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (LTS:0HL9) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

AFMD:USA A28:Germany

Address

Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120

Website

https://www.affimed.com

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.

Affimed NV (LTS:0HL9) Headlines

No Headlines